2TYRING SK. Human papillomavirus infections: epidemiology, pathogeneisis, and host immune response[J]. J Am Acad Dermatol, 2000, 43: S 18～26.
3SIEGFRIED EC. Warts on children: an approach to therapy[J]. Pediatr Ann, 1996, 25(2): 79～90.
4JONES JB, HUTCHINSON PE. Modern treatment of warts: cure rates at 3 and 6 months[J]. Br J Dermatol, 1992, 127: 262～265.
5ADIMORA AA, QUINLIVAN EB. Human papillomavirus infection. Recent findings on progression to cervical cancer[J]. Postgrad Med, 1995, 98(3): 109～116.
6VEIEN NK, MADSEP SM, AVNACH W, et al. The treatment of plantar warts with a keratolytic agent and occlusion[J]. J Dermatol Treat, 1991, 2: 59～61.
7BENDER ME, SCHULT PP, NVEAUX JL, et al. Nonmosaic verruca plantaris: treatment with a salicylic acid polymeric matrix delivery system[J]. Cutis, 1991, 47: 199～200.
8VANHOOTEGHEM O, RICHERT B. BRASSINNE M. Raynaud phenomenon after treatment of verruca vulgaris of the sole with intralesional injection of bleomycin[J]. Pediatr Dermatol, 2001, 18(3): 249～251.
9VAN BREDERODE RL, ENGEL ED. Combined cryotherapy/70% salicylic acid treatment for plantar verrucase[J]. J Foot Ankle Surg, 2001, 40(1): 36～41.
10WIMMERSHOFF MB, SCHERER K, BAUMLER W, et al. Treatment of therapy-resistant verruca vulgaris with long-tunable dye laser[J]. Hautarzt, 2001, 52(8): 701～704.
